Prophylactic effect of tranexamic acid capsule in controlling epistaxis

Phase 3

• Conditions: Epistaxis.; Epistaxis; R04.0

• Registration Number: IRCT20180425039418N7
• Lead Sponsor: Zahedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Insensitivity to the drugs used in the study
Satisfaction to enter the study

Exclusion Criteria

Patients with seizure, arterial or venous thrombosis, leukemia, lymphoma, polycythemia vera, pregnant women
Patients who have taken anticoagulants, anti-platelets and even aspirin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient satisfaction from treatment based on questionnaire. Timepoint: Every week from the start of treatment and up to one month after treatment. Method of measurement: questionnaire.